Table 1.
The specific primary antibodies used in the current study.
| Antibody | Company | Dilution |
|---|---|---|
| anti-β-actin | Cell Signaling Technology, USA | 1:5,000 |
| Nox-4 | ABclonal, UK | 1:1,000 |
| p22phox | Santa Cruz Biotechnology, USA | 1:50 |
| sod1 | Proteintech, USA | 1:1,000 |
| Ho-1 | Abcam, UK | 1:1,000 |
| Nrf-2 | Santa Cruz Biotechnology, USA | 1:400 |
| Cox-2 | Cell Signaling Technology, USA | 1:500 |
| TNF-α | Millipore, USA | 1:1,000 |
| IL-1β | Abcam, UK | 1:1,000 |
| p-p65 | Cell Signaling Technology, USA | 1:1,000 |
| p65 | Cell Signaling Technology, USA | 1:3,000 |
| p-Akt | Cell Signaling Technology, USA | 1:2,000 |
| Akt | Cell Signaling Technology, USA | 1:3,000 |
| Bcl-2 | Cell Signaling Technology, USA | 1:2,000 |
| Bax | Cell Signaling Technology, USA | 1:2,000 |
| cleaved caspase-3 | Cell Signaling Technology, USA | 1:1,000 |
| caspase-3 | Cell Signaling Technology, USA | 1:3,000 |
| HRP-conjugated anti-rabbit IgG | Proteintech, USA | 1:5,000 |
| HRP-conjugated anti-mouse-IgG | Proteintech, USA | 1:5,000 |